Filing Flows › Alkermes (ALKS) › Recalls, complaints & regulation
Alkermes (ALKS): clinical trials
Alkermes (ALKS) beyond its filings: 9 active clinical trials.
Alkermes' latest quarter
Alkermes, Q3 2026: revenue $480M (+22% year over year), operating margin 7.5%, net earnings $16.3M, operating cash flow $93.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Alkermes have?
9 active studies on ClinicalTrials.gov, 6 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.